2024. ADVANTAGES OF USING LIPOSOME-ENCAPSULATED ANTIBIOTICS TO FIGHT INFECTIONS CAUSED BY ENTEROBACTERIA. Journal of Population Therapeutics and Clinical Pharmacology. 31, 9 (Sep. 2024), 731–740. DOI:https://doi.org/10.53555/nhwgvd87.